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132 Poster Presentation Abstractsand POSTN expression were performed by using quantitative real-time polymerase
chain reaction (qRT-PCR).
Results: These findings demonstrated that GPC-3 expression in musculoskeletal tu-
mors was significantly lower when compared to controls (pZ0.02). However,
POSTN expression in musculoskeletal tumor was not significantly different when
compared to that in controls.
Discussion and Conclusion: This study concluded that GPC-3 expression was signif-
icantly lower musculoskeletal tumor patients. Therefore, it can suggest that
neoplastic tissue had down regulated in cell division that causing GPC-3 had lower
expression when compared to that in non-neoplastic adjacent tissue. On the other
hand, POSTN expression in neoplastic tissue seemed to be higher than that in non-
neoplastic adjacent tissues, indicating that neoplastic tissues had abnormal devel-
opment. For further research, larger sample size will be necessary for validating
the results.
http://dx.doi.org/10.1016/j.jot.2016.06.181Session: Disease & Treatment e Ligament, Tendon and Meniscus
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RELATIVE TELOMERE LENGTH AND MITOCHONDRIA DNA COPY NUMBER IN
LIGAMENTUM FLAVUM OF LUMBAR STENOSIS PATIENTS
Sinsuda Dechsupa a, Worawat Limthongkul b, Wicharn Yingsakmongkol b,
Weerasak Singhatanadgige b, Sittisak Honsawek a
aDepartment of Biochemistry, Faculty of Medicine, Chulalongkorn University,
Thailand
bDepartment of Orthopaedics, Faculty of Medicine, Chulalongkorn University,
Thailand
Background: Degenerative lumbar disease is the common cause of low back pain.
In elderly patients, lumbar spinal stenosis is characterized by hypertrophic liga-
mentum flavum (LF), a decrease of elastin-to-collagen ratio, and age-related
fibrosis. Several studies have been reported that the telomere shortening was asso-
ciated with age and degenerative diseases. However, the association between the
telomere length and mitochondria DNA (mtDNA) copy number, and LF of lumbar
spinal stenosis is unknown. Therefore, the purposes of this study were to compare
the relative telomere length (RTL) and mtDNA copy number between non-patho-
logic and pathologic LF from lumbar spinal stenosis patients.
Subjects and Methods: A total of 33 patients with lumbar spinal stenosis were
recruited in the present study. RTL and mtDNA copy number of non-pathologic
and pathologic LF were performed by real-time polymerase chain reaction (qRT-
PCR).
Results: The results showed that pathologic LF tissue had significantly shorter
telomeres than non-pathologic LF tissue (pZ0.004). A significantly shortened
telomere length could be found in pathologic LF tissue within more than 60
years old group as compared to non-pathologic LF tissue (pZ0.023). RTL in path-
ologic LF tissue of female and male groups had significantly shorter telomere
than non-pathologic LF tissue (pZ0.038). Furthermore, there was significant
difference in RTL between female and male within pathologic LF group
(pZ0.27) between two groups, and there was no association in non-pathologic
and pathologic LF tissue between the RTL and mtDNA copy number from lumbar
stenosis patients.
Discussion and Conclusion: This study is the first to examine RTL in ligamentum
flavum of lumbar spinal stenosis patients. Our results showed that patients with
lumbar spinal stenosis displayed an accelerated telomere shortening in pathologic
LF tissue, as compared to non-pathologic LF tissues. The explanation for lower RTL
in pathologic LF tissue may be due to the high turnover rate of cell proliferation. In
accord with this study, Le Maitre et al. reported the mean telomere length was
significantly lower in degenerative disc than non-degenerative disc.
http://dx.doi.org/10.1016/j.jot.2016.06.182Session: Disease & Treatment e Tumors
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EZRIN PROMOTES METASTASIS AND INVASION OF OSTEOSARCOMA BY
UPREGULATING lncRNA HOTAIR VIA PI3K/Akt/IRF1 PATHWAY
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Background: Osteosarcomas are sarcomas of the bone with a high propensity to
metastasize. Ezrin is a member of the ezrin-radixin-moesin (ERM) family of pro-
teins that functions as a cross-linker between the actin cytoskeleton and the
plasma membrane, and plays a vital role in maintaining cell shape and polarity
and facilitates membrane-trafficking pathways, cell migration, cell signaling,
growth regulation, and differentiation. Extensively previous studies had elucidated
that ezrin promotes metastasis of osteosarcoma by activating PI3K/AKT pathway.Furthermore, it has been reported that AKT promotes HOTAIR, which is commonly
overexpressed in osteosarcoma and correlated with poor prognosis, by inhibiting
IRF1 expression in cancer cells. In this manuscript, we try to evaluate the mecha-
nisms of ezrin in promoting the metastasis and invasion of osteosarcoma, and the
relationship between ezrin and HOTAIR.
Subjects and methods: Transwell assays and Wound healing assay were conducted
to detect the influences of ezrin by using inhibitor small interfering RNA(siRNA).
The expression of MMP2/MMP9, AKT, p-AKT, IRF1 and HOTAIR were tested by
real-time PCR (RT-PCR) assays and Western blot. Furthermore, IRFI was knock-
downed and overexpressed to demonstrating the mechanisms of ezrin in regula-
tions of HOTAIR.
Results: The metastasis and invasion of osteosarcoma were suppressed by knock-
down of ezrin. The level of p-AKT and HOTAIR were reduced and IRF1 was upregu-
lated when silencing ezrin. Furthermore, the overexpression of IRF1
downregulated HOTAIR levels in MG63 cells; whereas, the knockdown of IRF1
expression had no obvious effect on HOTAIR expression.
Discussion and Conclusion: Human osteosarcoma usually presented a high ten-
dency to metastatic spread and caused poor outcomes, however, the underlying
mechanism was still largely unknown. Previous efforts had emerged that Ezrin
and HOTAIR are related with these procedures. In this study, we identified the
ezrin promotes metastasis and invasion of osteosarcoma by activating PI3K/AKT
pathway and downregulating IRF1, which binds to the HOTAIR promoter region,
resulting in promoting HOTAIR. Ezrin thus represents a promising target for the
development of novel and effective strategies aimed at preventing the progression
of osteosarcoma.
http://dx.doi.org/10.1016/j.jot.2016.06.183Session: Disease & Treatment e Osteoporosis
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Background: Dihydromyricetin (DMY), an active small molecule recently discov-
ered from natural medicines, can provide a wide range of health benefits. It was
demonstrated to have anti-inflammatory, antioxidant and anti-tumor effects,
also to improve insulin sensitivity of liver and skeletal muscle in nonalcoholic fatty
liver disease and diabetes. Inflammation and reactive oxygen species (ROS) has an
important role in postmenopausal osteoporosis, so we suppose that DMY also could
reduce inflammatory factors and ROS and inhibit ovariectomized (OVX)-mediated
bone loss.
Subjects and Methods: We used two animal models to test our hypothesis: OVX
and lipopolysaccharide (LPS, 5mg/kg)-induced bone loss models. We injected
DMY (200mg/kg) in intraperitoneally in OVX model for 6 weeks and in calvarial sur-
face in LPS model for 8 days. Bone structure and volume was evaluated by m-CT.
H&E, TRAP and immunohistochemical staining to assess related markers and cell
numbers.
Results: InOVXmodel, we scanning femurwithm-CTat 3weeks in vivo and 6weeks in
vitro, after 3D reconstruction, BV/TV (8.6%), Tb.Th (13%) and Tb.N. (11.6%) signifi-
cantly increased but Tb.Sp (11.6%) decreased compared with sham group, it indi-
cated that DMY could significantly inhibit OVX induced bone loss. H&E and TRAP
staining also show that DMY treat group had fewer osteoclasts number compared
with sham group, and the adipose tissue volume decreased in DMY treat group.
Then we analyst peripheral subcutaneous adipose tissue (SAT, scapular region and
inguinal region), bone marrow adipose tissue (MAT) and visceral adipose tissue
(VAT) by immunohistochemical staining UCP-1, PPARa/g, C/EBPb, both SAT and
VAT has more UCP-1 expressing level than sham group, but PPAR-g, C/EBPb were
down-regulated; In LPS model, the whole calvarial stained with TRAP solution indi-
cated DMY also prevented LPS-induced bone destruction. Serum IL-1, IL-6, TNFa,
and ROS also decreased in both model of DMY group. In vitro study, DMY inhibit
LPS-stimulated RAW264.7 cell proliferation with a dose dependent manner without
influencing the viability of cells by CCK8. DMY also suppressed actin ring formation
and bone resorption and prevents RANKL-induced osteoclasts formation in vitro.
Western-blot and PCR results indicated that DMY down-regulated osteoclast differ-
entiation marker genes c-Fos, NFATc1 in RANKL-induced RAW264.7 cells.
Discussion and Conclusion: Our results indicated that DMY treatment significantly
reduced OVX and LPS-induced bone loss, and also induced WAT browning. We
hypothesised that DMY might induce adipose tissue white-to-brown to inhibit oste-
oclasts differentiation and function, and DMY also might promote osteoblasts dif-
ferentiation and bone formation in vivo. The crosstalk between bone and adipose
tissue and involved signaling pathway and regulatory factors need further
research.
http://dx.doi.org/10.1016/j.jot.2016.06.184
